Immunogenicity of tissue plasminogen activators in rhesus monkeys: Antibody formation and effects on blood level and enzymatic activity

Fundamental and Applied Toxicology

Volumn 30, Issue 2, 1996, Pages 243-254

  Zwickl, C M ^a   Hughes, B L ^a   Piroozi, K S ^a   Smith, H W ^a   Wierda, D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOGENICITY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RHESUS MONKEY; SERUM;

EID: 26844443905     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0062     Document Type: Article

References (25)

1. Albert, S. G., and Popp, D. A. (1984). Hypoglycemia due to serum-complexed insulin in a patient with diabetes mellitus. Diabetes Care 7, 285-290.
2. Aston, R., Cowden, W. B., and Ada, G. L. (1989). Review: Antibody-mediated enhancement of hormone activity. Mol. Immunol. 26, 435-446.
3. Bang, N. U., Wilhelm, O. G., and Clayman, M. D. (1989). Thrombolytic therapy in acute myocardial infarction. Annu. Rev. Pharmacol Toxicol. 29, 323-241.
4. Bell, W. R. (1994). Thrombolytic therapy: Agents, indications, and laboratory monitoring. Med. Clin. North Am. 78, 745-764.
5. Berzofsky, J. A., and Berkower, I. J. (1993). Immunogenicity and Antigen Structure. In Fundamental Immunology (W. E. Paul, Ed.), pp. 235-282. Raven Press, New York.
6. Burck, P. J., Berg, D. H., Warrick, M. W., Berg, D. T., Walls, J. D., Jaskunas, R., Crisel, R. M., Weigel, B., Vlahos, C. J., McClure, D. B., and Grinnell, B. W. (1990). Characterization of a modified human tissue plasminogen activator comprising a kringle-2 and a protease domain. J. Biol. Chem. 265, 5170-5177.
7. Collen, D. (1980). On the regulation and control of fibrinolysis. Thromb. Haemostasis 43, 77-89.
8. Fears, R., Hearn, J., Standring, R., Anderson, J. L., and Marder, V. J. (1992). Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction. Am. Heart J. 124, 305-314.
9. Gerard, R. D., and Meidell, R. S. (1989). Regulation of tissue plasminogen activator expression. Annu. Rev. Physiol. 51, 245-262.
10. Gill, J. L. (1978). Design and Analysis of Experiments in the Animal and Medical Sciences, Vol. 1, Iowa State Univ. Press, Ames, IA.
11. Graves, H. C. B. (1988). Noise control in solid-phase immunoassays by use of a matrix coat. J. Immunol. Methods 111, 167-178.
12. Grines, C. L. (1992). Thrombolytic, antiplatelet, and antithrombotic agents. Am. J. Cardiol. 70, 181-261.
13. Haire, W. D. (1992). Pharmacology of fibrinolysis. Chest 101, S91-97.
14. Hedner, U., and Nilsson, I. M. (1981). The role of fibrinolysis. Clin. Haematol. 10, 327-342.
15. Higgins, D. L., and Bennett, W. F. (1990). Tissue plasminogen activator: The biochemistry and pharmacology of variants produced by mutagenesis. Annu. Rev. Pharmacol Toxicol. 30, 91-121.
16. Jackson, C. V., Crowe, G., Craft, T. J., Sundboom, J. L., Gnnnell, B. W., Bobbitt, J. L., Burck, P. J., Quay, J. F., and Smith, G. F. (1990). Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis. Circulation 82, 930-940.
17. Jansen, J. W. C. M., and Reinders, J. H. (1992). Fibrinolysis: System and processes. Coronary Artery Dis. 3, 425-434.
18. Katsutani, N., Yoshitake, S., Takeuchi, H., Kelliher, J. C., Couch, R. C., and Shionoya, H. (1992). Immunogenic properties of structurally modified human tissue plasminogen activators in chimpanzees and mice. Fundam. Appl. Toxicol. 19, 555-562.
19. Mahmoud, M., and Gaffney, P. J. (1985). Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH). Thromb. Haemostasis 53, 356-359.
20. Nilsson, I. M., and Glow, B. (1962). Fibrinolysis induced by streptokinase in man. Acta Chir. Scand. 123, 247-266.
21. Takada, A., and Takada, Y. (1993). The physiology of the fibrinolytic system. Jpn. J. Physiol. 43, 1-19.
22. Zwickl, C. M., Smith, H. W., Tamura, R. N., and Bick, P. H. (1990). Somatotropin antibody formation in cows treated with a recombinant bovine somatotropin over two lactations. J. Dairy Sci. 73, 2888-2895.
23. Zwickl, C. M., Cocke, K. S., Tamura, R. N., Holzhausen, L. M., Brophy, G. T., Bick, P. H., and Wierda, D. (1991). Comparison of the immunogenicity of recombinant and pituitary human growth hormone in rhesus monkeys. Fundam. Appl. Toxicol. 16, 275-287.
24. Zwickl, C. M., Smith, H. W., and Wierda, D. (1994). Immunogenicity and effects of antibody on activity of tissue plasminogen activators in rhesus monkeys. Toxicologist 14, 219.
25. Zwickl, C. M., Smith, H. W., Zimmermann, J. L., and Wierda, D. (1995). Immunogenicity of biosynthetic human LysPro insulin compared to native-sequence human and purified porcine insulins in rhesus monkeys immunized over a 6-week period. Arzneim.-Forsch./Drug Res. 45, 524-528.